Showing results (3331-3340 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|July 23, 2003
Cytotoxic T cell responses against immunoglobulin in malignant and normal B cells: implications for tumor immunity and autoimmunityClair S Gricks, John G GribbenCurrent Pharmaceutical Design|July 23, 2003
Bioorganic approaches towards HIV vaccine designLai-Xi WangCurrent Pharmaceutical Design|July 23, 2003
Small-molecule HIV-1 integrase inhibitors: the 2001-2002 updateRaveendra Dayam, Nouri NeamatiCurrent Pharmaceutical Design|July 23, 2003
Genes and hypertensionE A Garcia, S Newhouse, M J Caulfield, et al.Current Pharmaceutical Design|October 9, 2002
The design of clinical trials for new molecularly targeted compounds: progress and new initiativesLesley SeymourCurrent Pharmaceutical Design|October 9, 2002
The shape of the messenger: using protein structure information to design novel cytokine-based therapeuticsCatherine H ScheinCurrent Pharmaceutical Design|October 9, 2002
Peptidic inhibitors of the hepatitis C virus serine protease within non-structural protein 3T O Fischmann, P C WeberCurrent Pharmaceutical Design|October 9, 2002
The aryl hydrocarbon receptor in anticancer drug discovery: friend or foe?T D Bradshaw, V Trapani, D A Vasselin, et al.Current Pharmaceutical Design|September 20, 2001
Lipid messengers as targets for antiangiogenic therapyE G Robert, J D HuntCurrent Pharmaceutical Design|July 23, 2002
Regulating cysteine protease activity: essential role of protease inhibitors as guardians and regulatorsBoris Turk, Dusan Turk, Guy S SalvesenPageof 1,008